Sarsia is an early-stage venture capital investor based in Bergen, Norway. We invest in science-based technology companies within blue economy / cleantech and green tech / deep tech and biotechnology/life sciences. Our strength lays in our technological competence, experience and extensive national and international network of industry and co-investors. Sarsia Seed Fund I started in 2007 is in the closing phase, after four IPOs, one SPAC out of the total 22 portfolio companies. 1bEUR has been created in shareholder value in the portfolio of Fund I since Sarsia entered as first institutional investor. Sarsia Seed Fund II has been operational since 2017. The total committed capital is 510 mnok, of which more than half has been called. Fund II is towards the end of its investment phase and has invested in 17 portfolio companies. Sarsia Fund III commenced operation in 2023, with a total committed capital of 367 mnok, and has entered its investment phase.
4
Total Investments
4
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Finance
Company Overview
About Sarsia
Recent Investments (4)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed | •••••• | Jun 2024 | |
| Seed | •••••• | Apr 2024 | |
| Series A | •••••• | Jan 2024 | |
| Venture Round | •••••• | Nov 2021 |
Latest News
Norway’s Birdsview raises €3.7 million to scale its “MRI for concrete” technology and protect infrastructure
Eu-startups · Aug 17, 2026
From Star Wars to King Arthur: 10 European startups with names drawn from fiction, folklore and religion
Eu-startups · Jul 22, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.